Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma

Thyroid cancer is generally curable and, in many cases, can be completely treated, although it can sometimes recur after cancer therapy. Papillary thyroid cancer (PTC) is known as one of the most general subtypes of thyroid cancer, which take up nearly 80% of whole thyroid cancer. However, PTC may d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hang-Seok, Kim, Yonjung, Lee, So Young, Yun, Hyeok Jun, Chang, Ho-Jin, Park, Ki Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138651/
https://www.ncbi.nlm.nih.gov/pubmed/37108231
http://dx.doi.org/10.3390/ijms24087069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138651/
https://www.ncbi.nlm.nih.gov/pubmed/37108231
http://dx.doi.org/10.3390/ijms24087069

Ejemplares similares